Literature DB >> 14673992

Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo.

W Hui1, A D Rowan, C D Richards, T E Cawston.   

Abstract

OBJECTIVE: To determine the effects of the proinflammatory cytokine combination of oncostatin M (OSM) and tumor necrosis factor alpha (TNFalpha) on cartilage destruction in both in vitro and in vivo model systems.
METHODS: The release of collagen and proteoglycan was assessed in bovine cartilage explant cultures, while messenger RNA (mRNA) from bovine chondrocytes was analyzed by Northern blotting. Immunohistochemistry was performed on sections prepared from murine joints following injection of adenovirus vectors encoding murine OSM and/or murine TNFalpha.
RESULTS: The combination of OSM + TNFalpha induced significant collagen release from bovine cartilage, accompanied by high levels of active collagenolytic activity. Northern blot analysis indicated that this cytokine combination synergistically induced matrix metalloproteinase 1 (MMP-1), MMP-3, and MMP-13 mRNA. The in vivo data clearly indicated that OSM + TNFalpha overexpression increased MMP levels and decreased levels of tissue inhibitor of metalloproteinases 1 (TIMP-1). Specifically, OSM + TNFalpha induced marked synovial hyperplasia, inflammation, and cartilage and bone destruction with a concomitant increase in MMP expression in both cartilage and synovium and decreased TIMP-1 expression in the articular cartilage. These effects were markedly greater than those seen with either cytokine alone.
CONCLUSION: This study demonstrates that OSM + TNFalpha represents a potent proinflammatory cytokine combination that markedly induces MMP production in both cartilage and synovium, thus promoting joint destruction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14673992     DOI: 10.1002/art.11333

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  39 in total

Review 1.  Non-invasive mouse models of post-traumatic osteoarthritis.

Authors:  B A Christiansen; F Guilak; K A Lockwood; S A Olson; A A Pitsillides; L J Sandell; M J Silva; M C H van der Meulen; D R Haudenschild
Journal:  Osteoarthritis Cartilage       Date:  2015-05-21       Impact factor: 6.576

2.  Oncostatin m promotes mammary tumor metastasis to bone and osteolytic bone degradation.

Authors:  Celeste Bolin; Ken Tawara; Caleb Sutherland; Jeff Redshaw; Patrick Aranda; Jim Moselhy; Robin Anderson; Cheryl L Jorcyk
Journal:  Genes Cancer       Date:  2012-02

3.  Oncostatin M in combination with tumour necrosis factor {alpha} induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2.

Authors:  W Hui; H E Barksby; D A Young; T E Cawston; N McKie; A D Rowan
Journal:  Ann Rheum Dis       Date:  2005-05-05       Impact factor: 19.103

4.  Suppression of MMP activity in bovine cartilage explants cultures has little if any effect on the release of aggrecanase-derived aggrecan fragments.

Authors:  Bijue Wang; Pingping Chen; Anne-Christine Bay Jensen; Morten A Karsdal; Suzi H Madsen; Bodil-Cecilie Sondergaard; Qinlong Zheng; Per Qvist
Journal:  BMC Res Notes       Date:  2009-12-18

5.  Investigation of the direct effects of salmon calcitonin on human osteoarthritic chondrocytes.

Authors:  Bodil-Cecilie Sondergaard; Suzi H Madsen; Toni Segovia-Silvestre; Sarah J Paulsen; Thorbjorn Christiansen; Christian Pedersen; Anne-Christine Bay-Jensen; Morten A Karsdal
Journal:  BMC Musculoskelet Disord       Date:  2010-04-05       Impact factor: 2.362

6.  Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds.

Authors:  K Migita; Y Izumi; T Torigoshi; K Satomura; M Izumi; Y Nishino; Y Jiuchi; M Nakamura; H Kozuru; F Nonaka; K Eguchi; A Kawakami; S Motokawa
Journal:  Clin Exp Immunol       Date:  2013-12       Impact factor: 4.330

7.  DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes.

Authors:  Ko Hashimoto; Richard O C Oreffo; Marc B Gibson; Mary B Goldring; Helmtrud I Roach
Journal:  Arthritis Rheum       Date:  2009-11

8.  Prediction of cartilage compressive modulus using multiexponential analysis of T(2) relaxation data and support vector regression.

Authors:  Onyi N Irrechukwu; Sarah Von Thaer; Eliot H Frank; Ping-Chang Lin; David A Reiter; Alan J Grodzinsky; Richard G Spencer
Journal:  NMR Biomed       Date:  2014-02-12       Impact factor: 4.044

9.  Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies.

Authors:  Ellen M Moran; Ronan Mullan; Jennifer McCormick; Mary Connolly; Owen Sullivan; Oliver Fitzgerald; Barry Bresnihan; Douglas J Veale; Ursula Fearon
Journal:  Arthritis Res Ther       Date:  2009-07-23       Impact factor: 5.156

10.  Delayed onset of changes in soma action potential genesis in nociceptive A-beta DRG neurons in vivo in a rat model of osteoarthritis.

Authors:  Qi Wu; James L Henry
Journal:  Mol Pain       Date:  2009-09-28       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.